{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:11:10Z","timestamp":1774368670453,"version":"3.50.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Pathol"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1309\/7p8u659jbjcv6eeu","type":"journal-article","created":{"date-parts":[[2007,10,23]],"date-time":"2007-10-23T12:52:55Z","timestamp":1193143975000},"page":"776-782","source":"Crossref","is-referenced-by-count":97,"title":["Podoplanin (D2-40) Is a Novel Marker for Follicular Dendritic Cell Tumors"],"prefix":"10.1093","volume":"128","author":[{"given":"Hongbo","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna A.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geraldine S.","family":"Pinkus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason L.","family":"Hornick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2007,11,1]]},"reference":[{"key":"E00001","unstructured":"Breiteneder-Geleff S, Matsui K, Soleiman A, et al. Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. <i>Am J Pathol<\/i>. 1997; 151:1141-1152."},{"key":"E00002","doi-asserted-by":"crossref","unstructured":"Breiteneder-Geleff S, Soleiman A, Kowalski H, et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. <i>Am J Pathol<\/i>. 1999; 154:385-394.","DOI":"10.1016\/S0002-9440(10)65285-6"},{"key":"E00003","doi-asserted-by":"crossref","unstructured":"Ordonez NG. Podoplanin: a novel diagnostic immunohistochemical marker. <i>Adv Anat Pathol<\/i>. 2006; 13:83-88.","DOI":"10.1097\/01.pap.0000213007.48479.94"},{"key":"E00004","doi-asserted-by":"crossref","unstructured":"Schacht V, Ramirez MI, Hong Y-K, et al. T1a\/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. <i>EMBO J<\/i>. 2003; 22:3546-3556.","DOI":"10.1093\/emboj\/cdg342"},{"key":"E00005","doi-asserted-by":"crossref","unstructured":"Schacht V, Dadras SS, Johnson LA, et al. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. <i>Am J Pathol<\/i>. 2005; 166:913-921.","DOI":"10.1016\/S0002-9440(10)62311-5"},{"key":"E00006","unstructured":"Sugimoto Y, Watanabe M, Oh-hara T, et al. Suppression of experimental lung colonization of a metastatic variant of murine colon adenocarcinoma 26 by a monoclonal antibody 8F11 inhibiting tumor cell-induced platelet aggregation. <i>Cancer Res.<\/i> 1991; 51:921-925."},{"key":"E00007","unstructured":"Watanabe M, Okochi E, Sugimoto Y, et al. Identification of a platelet-aggregating factor of murine colon adenocarcinoma 26: Mr 44,000 membrane protein as determined by monoclonal antibodies. <i>Cancer Res<\/i>. 1988; 48:6411-6416."},{"key":"E00008","doi-asserted-by":"crossref","unstructured":"Kato Y, Fujita N, Kunita A, et al. Molecular identification of Aggrus\/T1a as a platelet aggregation-inducing factor expressed in colorectal tumors. <i>J Biol Chem<\/i>. 2003; 278:51599-51605.","DOI":"10.1074\/jbc.M309935200"},{"key":"E00009","doi-asserted-by":"crossref","unstructured":"Kato Y, Sasagowa I, Kaneko M, et al. Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors. <i>Oncogene<\/i>. 2004; 23:8552-8556.","DOI":"10.1038\/sj.onc.1207869"},{"key":"E00010","doi-asserted-by":"crossref","unstructured":"Marks A, Sutherland DR, Bailey D, et al. Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumors. <i>Br J Cancer<\/i>. 1999; 80:569-578.","DOI":"10.1038\/sj.bjc.6690393"},{"key":"E00011","unstructured":"Jaffe ES, Harris NL, Stein H, et al, eds. <i>Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues<\/i>. Lyon, France: IARC Press; 2001. <i>World Health Organization Classification of Tumours<\/i>."},{"key":"E00012","unstructured":"Fletcher CDM, Unni KK, Mertens F, eds. <i>Pathology and Genetics of Tumours of the Soft Tissues and Bones<\/i>. Lyon, France: IARC Press; 2002. <i>World Health Organization Classification of Tumours<\/i>."},{"key":"E00013","unstructured":"Perez-Ordonez B, Rosai J. Follicular dendritic cell tumor: review of the entity. <i>Semin Diagn Pathol<\/i>. 1998; 15:144-154."},{"key":"E00014","doi-asserted-by":"crossref","unstructured":"Chan JK, Fletcher CD, Nayler SJ, et al. Follicular dendritic cell sarcoma: clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. <i>Cancer<\/i>. 1997; 79:294-313.","DOI":"10.1002\/(SICI)1097-0142(19970115)79:2<294::AID-CNCR13>3.0.CO;2-W"},{"key":"E00015","doi-asserted-by":"crossref","unstructured":"Isaacson PG, Matutes E, Burke M, et al. The histopathology of splenic lymphoma with villous lymphocytes. <i>Blood<\/i>. 1994; 84:3828-3834.","DOI":"10.1182\/blood.V84.11.3828.bloodjournal84113828"},{"key":"E00016","doi-asserted-by":"crossref","unstructured":"Papadaki T, Stamatopoulos K, Belessi C, et al. Splenic marginal-zone lymphoma: one or more entities? a histologic, immunohistochemical, and molecular study of 42 cases. <i>Am J Surg Pathol<\/i>. 2007; 31:438-446.","DOI":"10.1097\/01.pas.0000213419.08009.b0"},{"key":"E00017","doi-asserted-by":"crossref","unstructured":"Grogg KL, Lae ME, Kurtin PJ, et al. Clusterin expression distinguishes follicular dendritic cell tumors from other dendritic cell neoplasms: report of a novel follicular dendritic cell marker and clinicopathologic data on 12 additional follicular dendritic cell tumors and 6 additional interdigitating dendritic cell tumors. <i>Am J Surg Pathol<\/i>. 2004; 28:988-998.","DOI":"10.1097\/01.pas.0000112536.76973.7f"},{"key":"E00018","doi-asserted-by":"crossref","unstructured":"Grogg KL, Macon WR, Kurtin PJ, et al. A survey of clusterin and fascin expression in sarcomas and spindle cell neoplasms: strong clusterin immunostaining is highly specific for follicular dendritic cell tumor. <i>Mod Pathol<\/i>. 2005; 18:260-266.","DOI":"10.1038\/modpathol.3800294"},{"key":"E00019","doi-asserted-by":"crossref","unstructured":"Pileri SA, Grogan TM, Harris NL, et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. <i>Histopathology<\/i>. 2002; 41:1-29.","DOI":"10.1046\/j.1365-2559.2002.01418.x"},{"key":"E00020","doi-asserted-by":"crossref","unstructured":"Fonseca R, Yamakawa M, Nakamura S, et al. Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma: a review. <i>Am J Hematol<\/i>. 1998; 59:161-167.","DOI":"10.1002\/(SICI)1096-8652(199810)59:2<161::AID-AJH10>3.0.CO;2-C"},{"key":"E00021","doi-asserted-by":"crossref","unstructured":"Fukunaga M. Expression of D2-40 in lymphatic endothelium of normal tissue and in vascular tumors. <i>Histopathology<\/i>. 2005; 46:396-402.","DOI":"10.1111\/j.1365-2559.2005.02098.x"},{"key":"E00022","doi-asserted-by":"crossref","unstructured":"Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. <i>Mod Pathol<\/i>. 2002; 15:434-440.","DOI":"10.1038\/modpathol.3880543"},{"key":"E00023","doi-asserted-by":"crossref","unstructured":"Pyakurel P, Pak F, Mwakigonja AR, et al. Lymphatic and vascular origin of Kaposi's sarcoma spindle cells during tumor development. <i>Int J Cancer<\/i>. 2006; 119:1262-1267.","DOI":"10.1002\/ijc.21969"},{"key":"E00024","doi-asserted-by":"crossref","unstructured":"Debelenko LV, Perez-Atayde AR, Mulliken JB, et al. D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma. <i>Mod Pathol<\/i>. 2005; 18:1454-1460.","DOI":"10.1038\/modpathol.3800444"},{"key":"E00025","doi-asserted-by":"crossref","unstructured":"Franke FE, Steger K, Marks A, et al. Hobnail hemangiomas (targetoid hemosiderotic hemangiomas) are true lymphangiomas. <i>J Cutan Pathol<\/i>. 2004; 31:362-367.","DOI":"10.1111\/j.0303-6987.2004.00192.x"},{"key":"E00026","doi-asserted-by":"crossref","unstructured":"Ordonez NG. D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma. <i>Hum Pathol<\/i>. 2005; 36:372-380.","DOI":"10.1016\/j.humpath.2005.01.019"},{"key":"E00027","doi-asserted-by":"crossref","unstructured":"Dumoff KL, Chu C, Xu X, et al. Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinomas of the uterine cervix. <i>Mod Pathol<\/i>. 2005; 18:97-104.","DOI":"10.1038\/modpathol.3800269"},{"key":"E00028","doi-asserted-by":"crossref","unstructured":"Kahn H, Marks A. A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. <i>Lab Invest<\/i>. 2002; 82:1255-1257.","DOI":"10.1097\/01.LAB.0000028824.03032.AB"},{"key":"E00029","doi-asserted-by":"crossref","unstructured":"Biermann K, Klingmuller D, Koch A, et al. Diagnostic value of markers M2A, OCT3\/4, AP-2\u03b3, PLAP and c-KIT in the detection of extragonadal seminomas. <i>Histopathology<\/i>. 2006; 49:290-297.","DOI":"10.1111\/j.1365-2559.2006.02496.x"},{"key":"E00030","doi-asserted-by":"crossref","unstructured":"Yu H, Pinkus GS, Hornick JL. Diffuse membranous immunoreactivity for podoplanin (D2-40) distinguishes primary and metastatic seminomas from other germ cell tumors and metastatic neoplasms. <i>Am J Clin Pathol<\/i>. 2007; 128:767-775.","DOI":"10.1309\/4GMREAULY257R3AY"},{"key":"E00031","doi-asserted-by":"crossref","unstructured":"Chu AY, Litzky LA, Pasha TL, et al. Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. <i>Mod Pathol<\/i>. 2005; 18:105-110.","DOI":"10.1038\/modpathol.3800259"},{"key":"E00032","doi-asserted-by":"crossref","unstructured":"Ordonez NG. The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between peritoneal mesotheliomas and serous carcinomas: a comparative study. <i>Mod Pathol<\/i>. 2006; 19:34-38.","DOI":"10.1038\/modpathol.3800471"},{"key":"E00033","doi-asserted-by":"crossref","unstructured":"Ordonez NG. The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study. <i>Mod Pathol<\/i>. 2006; 19:417-428.","DOI":"10.1038\/modpathol.3800544"},{"key":"E00034","doi-asserted-by":"crossref","unstructured":"Muller AM, Franke FE, Muller KM. D2-40: a reliable marker in the diagnosis of pleural mesothelioma. <i>Pathobiology<\/i>. 2006; 73:50-54.","DOI":"10.1159\/000093091"},{"key":"E00035","unstructured":"Kimura N, Kimura I. Podoplanin as a marker for mesothelioma. <i>Pathol Int.<\/i> 2005; 55:83-86."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/128\/5\/776\/4988772\/ajcpath128-0776.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T10:00:18Z","timestamp":1587981618000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article-lookup\/doi\/10.1309\/7P8U659JBJCV6EEU"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2007,11,1]]},"published-print":{"date-parts":[[2007,11]]}},"alternative-id":["10.1309\/7P8U659JBJCV6EEU"],"URL":"https:\/\/doi.org\/10.1309\/7p8u659jbjcv6eeu","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}